Home » Stocks » Protalex

Protalex, Inc. (PRTX)

Stock Price: $0.0001 USD 0.0000 (0.00%)
Updated Oct 23, 2020 9:30 AM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 4,733
Revenue (ttm) n/a
Net Income (ttm) -4.65M
Shares Out 47.33M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $0.0001
Previous Close $0.0001
Change ($) 0.0000
Change (%) 0.00%
Day's Open 0.0001
Day's Range 0.0001 - 0.0001
Day's Volume 0
52-Week Range - 0.02

More Stats

Market Cap 4,733
Enterprise Value 2.12M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 47.33M
Float 6.15M
EPS (basic) -0.13
EPS (diluted) -0.12
FCF / Share -0.06
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 546.86
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 48.10
Revenue n/a
Operating Income -4.06M
Net Income -4.65M
Free Cash Flow -2.94M
Net Cash -2.12M
Net Cash / Share -0.04
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -732.51%
ROE n/a
ROIC -395.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-4.42-4.01-8.98-11.30-11.57-5.62-3.50-2.64-2.97-7.29
Net Income-5.04-4.56-9.42-11.62-11.85-6.28-4.44-3.36-3.07-7.23
Shares Outstanding33.5528.7728.7728.7726.2218.9318.9315.7710.545.72
Earnings Per Share-0.15-0.16-0.33-0.40-0.45-0.33-0.23-0.22-0.29-1.25
Operating Cash Flow-3.38-3.94-4.28-3.99-4.62-4.73-2.35-2.81-3.32-6.01
Capital Expenditures--------0.020.20
Free Cash Flow-3.38-3.94-4.28-3.99-4.62-4.73-2.35-2.81-3.30-5.81
Cash & Equivalents0.560.490.440.931.612.460.191.542.352.65
Total Debt2.1021.7917.2513.029.4010.272.600.660.59-
Net Cash / Debt-1.55-21.30-16.81-12.09-7.78-7.81-2.410.881.762.65
Book Value-2.10-21.74-17.36-12.59-8.18-8.50-3.120.491.071.28
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Protalex, Inc.
Country United States
Employees 2

Stock Information

Ticker Symbol PRTX
Stock Exchange US OTC
Sector Healthcare
Industry Drug Manufacturers - Other
Unique Identifier OTCMKTS: PRTX
IPO Date January 11, 2000


Protalex focuses on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases in the United States. The company targets a range of autoimmune diseases, such as rheumatoid arthritis (RA), immune thrombocytopenia (ITP), psoriasis, myasthenia gravis, chronic idiopathic demyelinating polyneuropathy, and pemphigus. Its lead product candidate is PRTX-100, an immunomodulatory therapy, a highly-purified form of staphylococcal protein A, which is in Phase I/II open-label, dose-escalating study for the treatment of patients with persistent/chronic ITP; and Phase 1b clinical trial for the treatment of RA on methotrexate or leflunomide. The company was founded in 1999 and is based in Florham Park, New Jersey.